Purchase Order HT942524P0042
Award Date
4/8/24
Potential Completion Date
11/7/24
Potential Value
$250K
Federal Agency
Defense Health Agency
Awardee
Glyphic Biotechnologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10016, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase I
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DHA) awarded a $249,991.63 firm-fixed-price purchase order to Fabrico Technology, Inc., a minority-owned, Asian-Pacific American owned, small business, for research and development under the STTR Phase I program. The contract is for the "Development of Antibody Treatment of MDR ESKAPE Pathogen, P. aeruginosa" and has a performance period extending to November 30, 2024. This contract is a small business set-aside, reflecting Fabrico's status as a qualified...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Synbio Technologies LLC, a minority-owned small business. The contract is for the procurement of a synthetic plasmid containing the AP50c phage genome, modified to include an eGFP tag, for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The total contract value is $11,994.20, with a completion date of June 24, 2024. The...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Guild Associates Inc. (doing business as Guild Biosciences), a small business manufacturer. The contract, valued at $223,743, is for the development of "PHAGE-FUNCTIONALIZED MICROPILLARDEVICES FOR SELECTIVE BACTERIAL COLLECTION." This research project aims to create innovative...
This is a Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Cancer Institute (NCI) to Glycoscientific, L.L.C., a small business research company. The contract is for the development of glycosylation-specific research reagents, including antibodies and aptamers, under SBIR Topic 294 Phase I. The contract has a ceiling value of $149,951 and was awarded on a firm fixed-price basis. This contract was set aside for total small business...
This is a $1,264,126.01 firm-fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Green Mountain Antibodies Inc. for research and development services related to developing monoclonal antibodies against the ESKAPEE pathogens. The contract has a base period of performance from September 30, 2020 to September 29, 2021, with four one-year option periods extending the potential completion date to September 29, 2025. This contract was awarded on a sole-source basis to a small...
The U.S. Defense Health Agency (DHA) awarded a $999,975.57 Small Business Innovation Research (SBIR) Phase II contract to Guild Associates, Inc. (doing business as Guild Biosciences) for the development of "Pathogen-Specific and Serotype-Independent Antibody Reagents for Diagnosis of Shigella spp. and Non-Typhoidal Salmonella." This Firm Fixed Price contract was set aside for small businesses and has an ultimate completion date of August 23, 2021. Guild Associates, a manufacturer of...
This federal contract award was made by the Defense Health Agency (DHA) to Erivan Bio, LLC, a for-profit limited liability company, for a Small Business Technology Transfer (STTR) Phase I research project titled "Novel Scalable Loading of Antibiotics in Exosomes for Bacterial Wound Infection Prevention". The contract has a firm fixed price of $249,981.86 and a completion date of September 22, 2024. This STTR Phase I award supports research and development to develop a novel approach...
This federal contract award was issued by the Defense Health Agency (DHA) to Charlot Biosciences Inc., a minority-owned, small disadvantaged business, for a Phase I Small Business Innovation Research (SBIR) project titled "Rapid Detection of Bacteriophage Susceptibility in Antibiotic-Resistant Pathogens Using Cellphoresis". The firm-fixed-price purchase order has a potential value of $249,534.00 and a completion date of September 7, 2021. The contract is set aside for small...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Glycohub, Inc., a woman-owned small business. The contract is for the delivery of chemically defined glycosphingolipid head groups, with a total ceiling value of $298,447.00 and a completion date of December 30, 2014. As an SBIR Phase I contract, this represents the initial research and development effort to explore the feasibility of the proposed technology....
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...